Cotización Cytocom - CBLI

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

3.17

Postura de Compra

3.18

Postura de Venta

3.41

Volume Operado de la Acción

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

3.17

Precio de Apertura

Hora

Última hora de negociación

Volumen promedio (3 m)

Volumen financiero

Precio Promedio Ponderado

Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."

Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc." New Corporate...

Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast

Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast Audio archive...

Cytocom, Inc. Reports Second Quarter 2021 Financial Results

Cytocom, Inc. Reports Second Quarter 2021 Financial Results -All-stock merger transaction between legacy...

Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement

Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement Cytocom to...

Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference

Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business...

Cytocom, Inc. to Report Second Quarter 2021 Financial Results

Cytocom, Inc. to Report Second Quarter 2021 Financial Results Executive Management to Host Conference Call on...

Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19

Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and...

Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs

Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs PR Newswire FORT COLLINS, Colo., Aug...

Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing

Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing Financing Led by GEM Global...

Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger

Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CBLI - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cytocom?

El precio actual de las acciones de Cytocom es US$ 3.17

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cytocom?

Cytocom ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
RDUSRadius Recycling Inc	US$ 28.58 (109.22%)	134.98k
BONBon Natural Life Ltd	US$ 1.50 (103.89%)	19.26M
UOKAMDJM Ltd	US$ 0.2518 (56.69%)	65.91M
AAOIApplied Optoelectronics Inc	US$ 24.00 (51.23%)	1.17M
TOIOncology Institute Inc	US$ 0.90 (38.48%)	6
TLFTandy Leather Factory Inc	US$ 2.01 (-32.55%)	1
CEADCEA Industries Inc	US$ 6.01 (-30.12%)	12
YMABY mAbs Therapeutics Inc	US$ 3.41 (-27.91%)	71
NEGGNewegg Commerce Inc	US$ 0.2799 (-26.92%)	481.1k
NAYANAYA Biosciences Inc	US$ 0.24 (-25.26%)	26.28k
UOKAMDJM Ltd	US$ 0.2518 (56.69%)	65.91M
BTOGBit Origin Ltd	US$ 0.3505 (28.44%)	45.59M
HEPAHepion Pharmaceuticals Inc	US$ 0.0289 (-23.54%)	28.72M
DGLYDigital Ally Inc	US$ 0.0827 (4.16%)	25.14M
BONBon Natural Life Ltd	US$ 1.50 (103.89%)	19.26M

No se encontraron comentarios

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

Cytocom Inc (CBLI)

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

CBLI Últimas noticias

Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."

Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast

Cytocom, Inc. Reports Second Quarter 2021 Financial Results

Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement

Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference

Cytocom, Inc. to Report Second Quarter 2021 Financial Results

Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19

Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs

Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing

Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger

CBLI - Preguntas Frecuentes

Movimientos

CBLI Discussion

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Tendencias Ahora

Listas Principales

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

Cytocom Inc (CBLI) Cotización

Cytocom Inc (CBLI)

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

CBLI Últimas noticias

Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."

Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast

Cytocom, Inc. Reports Second Quarter 2021 Financial Results

Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement

Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference

Cytocom, Inc. to Report Second Quarter 2021 Financial Results

Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19

Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs

Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing

Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger

CBLI - Preguntas Frecuentes

Movimientos

CBLI Discussion

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Quitar anuncios

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS